Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Abstract: Generative artificial intelligence has become the focus of the intelligent education field, especially in the generation of personalized learning resources. Current learning resource ...
Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. 2025 was a slow year for IPOs, with ...
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
Champions League permutations: What every team needs to qualify for the round of 16 or the playoffs?
The Champions League league phase is coming to an end. In a breath-stopping final matchday, with all 18 games kicking off simultaneously, almost everything is still up for grabs. The only certainties ...
Abstract: Valuable information and knowledge can be learned from users’ location traces and support various location-based applications such as intelligent traffic control, incident response, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results